Maccauro, M., Cuomo, M., Bauckneht, M., Bagnalasta, M., Mazzaglia, S., Scalorbi, F., . . . Chiesa, C. (2025). Correction to: The LUTADOSE trial: tumour dosimetry after the first administration predicts progression free survival in gastro‑entero‑pancreatic neuroendocrine tumours (GEP NETs) patients treated with [177Lu] Lu‑DOTATATE. European Journal of Nuclear Medicine & Molecular Imaging, 52(13), 5208-5209.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Maccauro, Marco, et al. "Correction to: The LUTADOSE Trial: Tumour Dosimetry After the First Administration Predicts Progression Free Survival in Gastro‑entero‑pancreatic Neuroendocrine Tumours (GEP NETs) Patients Treated with [177Lu] Lu‑DOTATATE."
European Journal of Nuclear Medicine & Molecular Imaging 52, no. 13 (2025): 5208-5209.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Maccauro, Marco, et al. "Correction to: The LUTADOSE Trial: Tumour Dosimetry After the First Administration Predicts Progression Free Survival in Gastro‑entero‑pancreatic Neuroendocrine Tumours (GEP NETs) Patients Treated with [177Lu] Lu‑DOTATATE."
European Journal of Nuclear Medicine & Molecular Imaging, vol. 52, no. 13, 2025, pp. 5208-5209.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.